These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8270243)

  • 1. Liver abscess after percutaneous ethanol injection (PEI) therapy for hepatocellular carcinoma. A case report.
    Okada S; Aoki K; Okazaki N; Nose H; Yoshimori M; Shimada K; Yamamoto J; Takayama T; Kosuge T; Yamasaki S
    Hepatogastroenterology; 1993 Oct; 40(5):496-8. PubMed ID: 8270243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver abscess complicating intratumoral ethanol injection therapy for HCC.
    Isobe H; Fukai T; Iwamoto H; Satoh M; Tokumatsu M; Sakai H; Andoh B; Sakamoto S; Nawata H
    Am J Gastroenterol; 1990 Dec; 85(12):1646-8. PubMed ID: 2174643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
    Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection.
    Ishii H; Okada S; Okusaka T; Yoshimori M; Nakasuka H; Shimada K; Yamasaki S; Nakanishi Y; Sakamoto M
    Cancer; 1998 May; 82(9):1638-42. PubMed ID: 9576282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular carcinoma recurrence in PEI site--a case report].
    Ota H; Nagano H; Sakon M; Inoue T; Hayashi S; Kondo M; Arai I; Morimoto O; Yamamoto T; Nakamura M; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2421-4. PubMed ID: 12484090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
    Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
    Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Ohnishi K
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1254-8. PubMed ID: 9730384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of cases with liver abscess following transcatheter arterial chemoembolization (TAE) for malignant hepatic tumors].
    Ishikawa H; Kanai T; Ono T; Shimoyama Y; Aizawa K; Ishida H; Saitoh Y; Hata H; Aoki A; Okuda S
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2233-6. PubMed ID: 7944448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal hemorrhage as a major complication of percutaneous ethanol injection therapy for hepatocellular carcinoma.
    Ohmoto K; Kunieda T; Shibata N; Yamamoto S
    Hepatogastroenterology; 2000; 47(35):1199-202. PubMed ID: 11100310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma.
    Ferlitsch A; Kreil A; Bauer E; Schmidinger H; Schillinger M; Gangl A; Peck-Radosavljevic M
    Eur J Clin Invest; 2004 Mar; 34(3):218-23. PubMed ID: 15025681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates.
    Castroagudín JF; Delgado M; Villanueva A; Bustamante M; Martínez J; Otero E; Tomé S; Martínez SM; Segade FR; Conde R; Dominguez-Muñoz E; Varo E
    Transplant Proc; 2005 Nov; 37(9):3871-3. PubMed ID: 16386568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
    Ishii H; Okada S; Nose H; Okusaka T; Nagahama H; Nakayama H; Nakasuka H; Yoshimori M
    Hepatogastroenterology; 1996; 43(10):938-43. PubMed ID: 8884317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC).
    Macías-García F; Vallejo-Senra N; Baleato-González S; Fernández-Castroagudín J; Molina-Pérez E; Domínguez-Muñoz J
    Rev Esp Enferm Dig; 2013 Feb; 105(2):110-2. PubMed ID: 23659512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.
    Ishii H; Okada S; Nose H; Okusaka T; Yoshimori M; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
    Cancer; 1996 May; 77(9):1792-6. PubMed ID: 8646676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
    Arata S; Tanaka K; Okazaki H; Kondo M; Morimoto M; Saito S; Numata K; Nakamura S; Sekihara H
    Hepatogastroenterology; 2001; 48(38):480-5. PubMed ID: 11379338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment for recurrent hepatocellular carcinoma].
    Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):327-32. PubMed ID: 9492824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.